Hongyu Fang, M.D., M.S.

(877) 524-4673
Hongyu Fang, M.D., M.S.
Anesthesiologist
Clinical Expertise
  • Anesthesiology
Additional Contacts
  • Referring Physicians Phone
    (847) 746-9990
  • Referring Physicians Fax
    (847) 342-4089
  • Referring Physicians Email
    [email protected]

Hongyu Fang, M.D., joined City of Hope® Cancer Center Chicago in 2012 as an anesthesiologist, supporting patients in controlling pain and monitoring vital levels during surgical procedures.

Dr. Fang earned his Doctor of Medicine degree at Jilin Medical College, followed by a residency in urology and surgery at the Beijing Friendship Hospital from 1993 to 1997. He completed his Master of Science in Biology at Andrews University in Michigan, then pursued postgraduate research for many years. He served as a research assistant at Andrews University in Michigan from 1997 to 2000 and held multiple research and academic positions at the University of Virginia, including Research Instructor in the Department of Anesthesiology, before completing an additional residency in anesthesiology at the Medical College of Wisconsin.

Dr. Fang is board certified in anesthesiology by the American Board of Anesthesiology and is a member of the Society of Medicine in China, the International Anesthesiology Research Society and the American Medical Association.

As a medical researcher, Dr. Fang has studied many aspects of anesthesiology. His research is published in renowned medical journals, and he has presented his work at numerous national and international conferences.

Location

Education & Experience

Board Certification

  • Anesthesiology — American Board of Anesthesiology

Degree

  • Jilin Medical College, China

Residencies

  • Urology & Surgery — Beijing Friendship Hospital, China
  • Anesthesiology — Medical College of Wisconsin, Milwaukee, WI

Fellowship

  • Anesthesiology — University of Virginia, Charlottesville, VA

Publications

  • Rajagopal S, Fang H, Lynch C 3rd, Kamatchi GL. Formalin-induced short- and long-term modulation of Cav currents expressed in Xenopus oocytes: an in vitro cellular model for formalin-induced pain. Basic Clin Pharmacol Toxicol. 2010 Apr;106(4):338-47.
  • Rajagopal S, Fang H, Oronce CI, Jhaveri S, Taneja S, Dehlin EM, Snyder SL, Sando JJ, Kamatchi GL. Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon. Neuroscience. 2009 Mar 17;159(2):618-28.
  • Rajagopal S, Fang H, Patanavanich S, Sando JJ, Kamatchi GL. (2008) Protein kinase C isozyme-specific potentiation of expressed Ca v 2.3 currents by acetyl-beta-methylcholine and phorbol-12-myristate, 13-acetate. Brain Res. 2008 May 19;1210:1-10.
  • Fang H, Patanavanich S, Rajagopal S, Yi X, Gill MS, Sando JJ, Kamatchi GL. (2006) Inhibitory role of Ser-425 of the alpha1 2.2 subunit in the enhancement of Cav 2.2 currents by phorbol-12-myristate,13-acetate. J Biol Chem. 2006 Jul 21;281(29):20011-7. Epub 2006 May 16.
  • Hongyu Fang, Ruthie Franke, Saharat Patanavanich, Amrita Lalani, Natalie Powell, Julianne Sando, Ganesan L. Kamatchi (2005), Role of alpha1 2.3 subunit I-II linker sites in the enhancement of Ca(v) 2.3 current by phorbol 12-myristate 13-acetate and acetyl-beta-methylcholine. J Biol Chem. 2005 Jun 24;280(25):23559-65.
  • Hongyu Fang, Yueming Huang, Zhiyi Zuo (2006), Enhancement of substrate-gated Cl- currents via rat glutamate transporter EAAT4 by PMA. Am J Physiol Cell Physiol. 2006 May;290(5):C1334-40.
  • Zhiyi Zuo and Hongyu Fang (2005), Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes. J Exp Biol. 2005 Jun 1;208(Pt 11):2063-70
  • Lim YJ, Huang Y, Fang H, Zuo Z Effects of local and intravenous anesthetics on the activity of glutamate transporter type 2. Brain Res Bull. 2003 Sep 30;61(5):537-40
  • Fang Hongyu et al , Modulation of the intestinal microflora by probiotics in children, Modern Practical Medicine 2003 (Chinese) Dec15(12): 734-737
  • Hongyu Fang, Yueming Huang, Zhiyi Zuo, The different responses of rat glutamate transporter type 2 and its mutant (tyrosine 403 to histidine) activity to volatile anesthetics and activation of protein kinase C. Brain Res. 2002 Oct 25;953(1-2):255-64